The Globe and Mail reports in its Wednesday, Aug. 20, edition that CIBC World Markets analyst Stephanie Price has elevated her recommendation for Thomson Reuters to "outperformer" from "neutral." The Globe's David Leeder writes that Ms. Price continues to target the shares at $201 (all figures U.S.). Analysts on average target the shares at $194.64. Ms. Price says in a note: "After posting solid Q2 results and a reiterated guidance that left our forward estimates largely unchanged, we are surprised at how much Thomson Reuters has sold off post quarter. We believe the sell-off was driven by expectations of a guidance raise with the quarter and from broader industry-wide AI disruption concerns. In our view, Thomson Reuters's 2025/2026 forecast and longer-term growth outlook remains unchanged as it rolls out GenAI tools from a position of competitive strength. With the stock down 13 per cent since earnings, and its year-to-date gains largely erased, we view current levels as a compelling entry point and as of Aug. 18 we are upgrading Thompson Reuters." The Globe reported on Aug. 8 that TD Cowen analyst Vince Valentini had reiterated his "hold" call for Thomson Reuters, which could then be had for $249.70.